When will Americans be able to get a COVID-19 antiviral pill?
CBSN
As the U.S. braces for a potential new wave of the virus this winter, there are promising signs that the first pill to treat COVID-19 in some at-risk Americans could be available by the end of the year.
A panel of the Food and Drug Administration's outside advisers is scheduled to meet on November 30 to weigh a potential emergency use authorization for molnupiravir, an antiviral drug developed by Merck that recently won authorization in the United Kingdom.
Merck says its drug halved the risk that adult COVID-19 patients with underlying health conditions ended up in the hospital or died from the disease.
It is common among older adults to not consistently get a full night's rest. But there are ways to improve sleep issues.
Microsoft is pulling the plug on Skype, the pioneering Internet telecommunications and video call platform it bought nearly 14 years ago for $8.5 billion.
Measles cases popping up across the United States, including an outbreak in Texas that has led to the death of a child, are prompting questions about where exactly the illness has been detected.